Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Epitomee MedicalEPTMF 27 Debt-to-Equity is 0.21 as of Dec. 2025, which is 75% above its 10-year median of 0.12. GuruFocus rates EPTMF with a GF Score™ of 27/100. The stock has 3 warning signs investors should review. Among 705 Medical Devices & Instruments companies, Epitomee Medical ranks better than 52.2% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Epitomee Medical's Debt-to-Equity or its related term are showing as below:
EPTMF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.12 Max: 1.7
Current: 0.21
During the past 8 years, the highest Debt-to-Equity Ratio of Epitomee Medical was 1.70. The lowest was 0.01. And the median was 0.12.
EPTMF's Debt-to-Equity is ranked better than 52.2% of 705
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs EPTMF: 0.21
Epitomee Medical (OTCPK:EPTMF) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Epitomee Medical Debt-to-Equity Related Terms
Epitomee Medical Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Epitomee Medical's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Epitomee Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Epitomee Medical Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Epitomee Medical's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Epitomee Medical's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Epitomee Medical (EPTMF) has a Debt-to-Equity of 0.21 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Epitomee Medical and its competitors. This is 75% above median its historical median of 0.12. Over the past decade, Epitomee Medical's Debt-to-Equity has ranged from 0.01 to 1.70. According to the industry distribution chart, Epitomee Medical ranks #337 out of 705 companies in the Medical Devices & Instruments industry, placing it in the top 47.8%.
Is Epitomee Medical's Debt-to-Equity too high?
Epitomee Medical's current Debt-to-Equity of 0.21 is 75% above median its 10-year median of 0.12. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 1.70. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. Epitomee Medical's value of 0.21 is 8.7% below this industry median. Based on the distribution chart, Epitomee Medical ranks #337 out of 705 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Epitomee Medical has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Epitomee Medical's Debt-to-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Epitomee Medical ranks #337 out of 705 companies for Debt-to-Equity. This puts Epitomee Medical in the upper half of its industry. The industry median Debt-to-Equity is 0.23. Epitomee Medical's value of 0.21 is 8.7% below this benchmark. Historically, Epitomee Medical's own Debt-to-Equity has ranged from 0.01 to 1.70 over the past decade. While the company's 10-year median is 0.12 vs. the industry median of 0.23, Epitomee Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Epitomee Medical's current Debt-to-Equity of 0.21 is 8.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Epitomee Medical and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epitomee Medical's current Debt-to-Equity is 0.21, which is 75% above median its own 10-year median of 0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epitomee Medical stock overvalued right now?
Epitomee Medical (EPTMF) has a current Debt-to-Equity of 0.21. The current Debt-to-Equity is 0.21, which is 75% above median its 10-year median of 0.12 and 8.7% below the Medical Devices & Instruments industry median of 0.23. Epitomee Medical's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Epitomee Medical (EPTMF), the current Debt-to-Equity is 0.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EPTMF has been successfully added to your 
